B3GNT3 expression was lower in patients with positive lymph node metastasis, implying a potential involvement of B3GNT3 in lymph node metastasis (Figure 7C). This evidence concerns the gene B3GNT3 and metastatic malignant neoplasm in the lymph nodes.